ZOL - Cardiology
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nuyens, Dieter
OCEAN, NCT02168829 / 2016-002353-38: Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Active, not recruiting
4
1284
Europe, Canada, RoW
Rivaroxaban, Xarelto, Acetylsalicylic acid, Aspirin, ASA
Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Bayer, Biotronik Canada Inc
Atrial Fibrillation, Stroke
07/25
08/25
NCT03505801: Confirm Rx Insertable Cardiac Monitor SMART Registry

Active, not recruiting
N/A
1826
Europe, Canada, Japan, US, RoW
Confirm Rx ICM insertion procedure
Abbott Medical Devices
Cardiac Arrhythmias, Symptoms and Signs, Atrial Fibrillation
09/19
03/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nuyens, Dieter
OCEAN, NCT02168829 / 2016-002353-38: Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Active, not recruiting
4
1284
Europe, Canada, RoW
Rivaroxaban, Xarelto, Acetylsalicylic acid, Aspirin, ASA
Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Bayer, Biotronik Canada Inc
Atrial Fibrillation, Stroke
07/25
08/25
NCT03505801: Confirm Rx Insertable Cardiac Monitor SMART Registry

Active, not recruiting
N/A
1826
Europe, Canada, Japan, US, RoW
Confirm Rx ICM insertion procedure
Abbott Medical Devices
Cardiac Arrhythmias, Symptoms and Signs, Atrial Fibrillation
09/19
03/26

Download Options